The need for nesting geriatric principles into modern care practice is urgent. Our health-care systems have been completely underestimating the role played by the aging process in the definition of clinical manifestations and diseases. 1 Given the fallacy of the standalone disease approach in the evaluation of the older person, several specialties are today looking with a mix of interest and anxiety to the geriatric literature, trying to find here some easy solutions to the aging of their patients and the increasing inadequacy of their protocols. The search inevitably ends at what geriatricians have been saying for years but has largely remained unheard: diseases are not EDITORIAL definition of a novel nosological condition respecting the requirements asked by regulatory agencies and paving the way for future pharmacological interventions against skeletal muscle decline. The definition designed by the SPRINT-T Consortium has been preliminarily endorsed by the European Medicines Agency. It translates the concept of physical frailty with the impairment captured by the Short Physical Performance Battery (SPPB), in the absence of mobility disability. 7 Why did the SPRINT-T project choose the SPPB instead of the frailty phenotype for capturing the clinical manifestation of the condition of interest? The SPPB is a robust, validated, replicable measure of physical performance based on timed tests.
the only center of action at old age, function should be the focus of interventions, the assessment of the individual should be comprehensive, and an integrated and multidisciplinary network of care is crucial. These concepts are difficult to understand, accept, and apply without the necessary background and willingness to change.
In this evolving scenario, words such as frailty and sarcopenia are increasingly used 2 and often misused. They are relatively easy to say and "see." The frailty phenotype is probably the most widely known and adopted measure of frailty. 3 Its five constituent criteria are easy to remember. Its design as a score also facilitates its implementation as it mirrors existing routine procedures in many settings and disciplines with questionnaires and scales. The five criteria make sense at representing a typical manifestation of the older individual. The characterization of frailty around the physical domain is of immediate acceptance, too; after all, we "see" the fragility of the person in his/her walking, strength, fatigue, weight loss, and inactivity.
On the one hand, the easy implementation of the frailty phenotype has substantially promoted discussions on aging and age-related conditions beyond the perimeter of geriatric medicine. On the other hand, it has oversimplified some concepts and created false (at least, to me) expectations. It is, today, frequent to perceive how the inner nature of frailty biology is confused with the instrument designed for its measurement. As soon as frailty is translated with the phenotype, it is automatically (and erroneously) forgotten that the age-related decline of homeostatic reserves 4 might also be hidden behind an excessive weight gain, a cognitive impairment in a physically fit person, or many signs and symptoms (eg, tremor, vision impairment, hearing loss, and dizziness) other than the five famous criteria.
The simplification of frailty with the phenotype can also be perceived in some automatisms and arguably easy solutions that, as geriatricians, we should reject. For example, the rigid association between the presence of a certain frailty criterion and the proposal of a specific intervention is frequently seen: if the person is losing weight, then introduce nutritional supplements; if the person is sedentary or weak, then recommend physical exercise, and so forth. In reality, we all know that targeting the symptoms is usually the wrong way to go, especially when dealing with the complexity of older per- 
